The Food and Drug Administration has granted Emergency Use Authorization for the Gilead Sciences, Inc., antiviral drug remdesivir to be used for health care...
Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, says preliminary results of a placebo-controlled, randomized trial with the Gilead...
Gilead Sciences, a biopharmaceutical company based in Foster City, California, today has announced that their drug remdesivir is showing promising results in a limited...
Daniel O’Day, the CEO of Gilead Sciences published an open letter on the biopharmaceutical company’s website warning that initial positive results of its drug...
The New England Journal of Medicine is reporting on a limited compassionate use trial of the drug Remdesivir. Doctors provided Remdesivir to 61 patients...